Recognised by the Government of India with DSIR accreditation
Our R&D teams identify and develop new products and non-infringing processes, manage technology transfer to manufacturing, and maintain GMP-compliant documentation from first experiment to commercial batch.
Proficient in the development of niche APIs such as Glycopyrronium Tosylate, Vilanterol and Valsartan. Our in-house centres are equipped for every reaction class we run at scale, with rotavapors, spray driers, lyophilizers and vacuum driers, supported by a fully equipped analytical R&D laboratory. Our Navi Mumbai (NM) R&D centre specializes in non-infringing process development for APIs and contract research, on computer-controlled reactors.
Generic formulation development across Diabetes, CVS, CNS and lifestyle therapies, using a QbD approach with First-to-File capability. Expertise spans Immediate Release, Modified Release (matrix & reservoir), orally disintegrating and chewable oral solids, with advanced pelletization on Innojet, Glatt and Hüttlin fluid-bed systems.
Drag the slider, or tap a stage, to see how a formulation travels from bench to plant without ever leaving Harman.
From routine QC to advanced characterization, our laboratories run on globally recognised instrument platforms. Hover over any instrument to see what runs behind it.
Fourier-Transform Infrared Spectroscopy
X-Ray Diffraction
Dissolution Testing Stations
Stability & Freeze-Thaw Chambers
Newtronics, ICH conditions
Liquid Chromatography, Tandem MS
High-Performance Liquid Chromatography





From niche API development to QbD-driven formulation, our scientists take on the projects others turn away.
Innovating Chemistry for Life – Health, Happiness & Harmony
Copyright © Harman Finochem Ltd. All Rights Reserved.